Literature DB >> 29428087

Evaluation of two-dimensional ultrasonography and computed tomography in the mapping and measuring of canine urinary bladder tumors.

S I Honkisz1, J F Naughton2, H Y Weng3, L M Fourez1, D W Knapp4.   

Abstract

Determining the dimensions of transitional cell carcinomas (TCCs) of the urinary bladder in dogs is important in assessing tumor progression and the response to treatment. The primary aim of this study was to evaluate the reliability of a standardized two-dimensional (2-D) ultrasound (US) protocol performed by a single experienced operator. Secondary aims were to compare World Health Organization (WHO) and Response Evaluation Criteria in Solid Tumors (RECIST) guidelines, and to compare measurements by two operators following these guidelines. These were evaluated by inter-operator and intra-operator reliability using the concordance correlation coefficient (CCC) and Cohen's κ statistics, which demonstrated substantial to better agreement by an experienced operator using either set of guidelines. It was demonstrated that 2-D US provides a reliable means to determine the dimensions of urinary bladder TCC when an experienced operator used a standardized protocol. In a subset of dogs, urinary bladder distension was varied, which resulted in differences in measurement with 2-D US and computed tomography.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Canine; Diagnostic imaging; Transitional cell carcinoma; Urothelial carcinoma

Mesh:

Year:  2017        PMID: 29428087     DOI: 10.1016/j.tvjl.2017.12.008

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  4 in total

1.  Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy.

Authors:  Marcus L Bradbury; Christine M Mullin; Shaban D Gillian; Chick Weisse; Philip J Bergman; Michelle A Morges; Lauren R May; David M Vail; Craig A Clifford
Journal:  Can Vet J       Date:  2021-02       Impact factor: 1.008

2.  Canine urinary bladder transitional cell carcinoma tumor volume is dependent on imaging modality and measurement technique.

Authors:  Andrew J Leffler; Eric T Hostnik; Emma E Warry; Gregory G Habing; Danelle M Auld; Eric M Green; Wm Tod Drost
Journal:  Vet Radiol Ultrasound       Date:  2018-07-10       Impact factor: 1.363

3.  Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma.

Authors:  Nicholas M Szigetvari; Deepika Dhawan; José A Ramos-Vara; Christopher P Leamon; Patrick J Klein; A Audrey Ruple; Hock Gan Heng; Michael R Pugh; Satish Rao; Iontcho R Vlahov; Pierre L Deshuillers; Philip S Low; Lindsey M Fourez; Ashleigh M Cournoyer; Deborah W Knapp
Journal:  Oncotarget       Date:  2018-12-11

4.  Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs.

Authors:  Shingo Maeda; Kosei Sakai; Kenjiro Kaji; Aki Iio; Maho Nakazawa; Tomoki Motegi; Tomohiro Yonezawa; Yasuyuki Momoi
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.